Ulipristal acetate; 126784-99-4; CDB-2914; Ella; EllaOne; CDB 2914; HRP 2000; Ulipristal acetate [USAN]; VA2914; (8S,11R,13S,14S,17R)-17-acetyl-11-(4-(dimethylamino)phenyl)-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate; (11beta)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione; YF7V70N02B; CHEBI:71025; 17-Acetoxy-11-(4-N,N-dimethylaminophenyl)pregna-4,9-diene-3,20-dione; PGL-4001; Ulipristal acetate(CDB2914); VA-2914; RTI-3021-012; Ulipristal (acetate); (11beta)-17-(Acetyloxy)-11-(4-(dimethylamino)phenyl)-19-norpregna-4,9-diene-3,20-dione; (11beta,17alpha)-17-acetyl-11-[4-(dimethylamino)phenyl]-3-oxoestra-4,9-dien-17-yl acetate; 17beta-acetyl-11beta-[4-(dimethylamino)phenyl]-3-oxoestra-4,9-dien-17alpha-yl acetate; (1R,3aS,3bS,10R,11aS)-1-acetyl-10-[4-(dimethylamino)phenyl]-11a-methyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl acetate; UNII-YF7V70N02B; Hrp-2000; Ulipristal acet; MFCD00899035; 4oar; Ulipristal-Acetate; Ella norpregnadiene; CBD 2914; Ella (TN); RTI 3021-012; C17 Epi Ulipristal Acetate; SCHEMBL544957; CHEMBL260538; GTPL7460; ULIPRISTAL ACETATE [MI]; Ulipristal acetate (JAN/USAN); ULIPRISTAL ACETATE [JAN]; DTXSID30155294; ta[a]phenanthren-17-yl] acetate; ULIPRISTAL ACETATE [VANDF]; ULIPRISTAL ACETATE [MART.]; [(8s,11r,13s,14s,17r)-17-Acetyl-11-[4-(Dimethylamino)phenyl]-13-Methyl-3-Oxo-1,2,6,7,8,11,12,14,15,16-Decahydrocyclopenta[a]phenanthren-17-Yl] Acetate; ULIPRISTAL ACETATE [WHO-DD]; ZINC3920657; BDBM50375424; Ulipristal acetate, >=98% (HPLC); AKOS026750526; CCG-269500; CS-1157; (11b)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione; ULIPRISTAL ACETATE [ORANGE BOOK]; NCGC00378913-02; [(8S,11R,13S,14S,17R)-17-acetyl-11-(4-dimethylaminophenyl)-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate; AS-73950; BU161520; HY-16508; U0102; C72119; D09687; EN300-220766; AB01566874_01; Q975059; J-005436; BRD-K64381438-001-03-8; Z2185283535; 5-(Hydroxymethyl)-alpha,alpha,alpha,alpha-tetramethyl-1,3-benzenediacetonitrile; (11.BETA.)-17-(ACETYLOXY)-11-(4-(DIMETHYLAMINO)PHENYL)-19-NORPREGNA-4,9-DIENE-3,20-DIONE; (8S,11R,13S,14S,17R)-17-acetyl-11-(4-(dimethylamino)phenyl)-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylacetate; 17.ALPHA.-ACETOXY-11.BETA.-(4-DIMETHYLAMINOPHENYL)-19-NORPREGNA-4,9-DIEN-3,20-DIONE; 19-Norpregna-4,9-diene-3,20-dione, 17-(acetyloxy)-11-(4-(dimethylamino)phenyl)-, (11beta)-; C17 Isomer Ulipristal Acetate; (10S,11S,14S,15S,17R)-14-Acetyl-17-[p-(dimethylamino)phenyl]-15-methyl-5-oxotetracyclo[8.7.0.02,7.011,15]heptadeca-1,6-dien-14-yl acetate; CBD 2914; VA 2914; (11b)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione